These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2519870

  • 1. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y, Shiraishi T, Tsuchitani T, Tobe T, Sugawara Y, Saito M, Kamiyama H.
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [Abstract] [Full Text] [Related]

  • 2. Splenectomy abolishes antitumor effect of immunotherapy with streptococcal preparation, OK-432, on mouse liver tumors.
    Imai S, Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tobe T.
    Anticancer Res; 1991; 11(3):1269-74. PubMed ID: 1888159
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F.
    Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
    [Abstract] [Full Text] [Related]

  • 4. [Oral administration of OK-432 is an effective immunotherapy against colon cancer--a study in a murine mesenteric lymphnode metastasis model].
    Nukata Y, Shiiba K, Ebine N, Ishii S, Matsuno S.
    Nihon Geka Gakkai Zasshi; 1995 Oct; 96(10):671-9. PubMed ID: 8538585
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H, Tsujitani S, Korenaga D, Kakeji Y, Haraguchi M, Konoe S, Maehara Y, Sugimachi K.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [Abstract] [Full Text] [Related]

  • 6. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 7. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
    Saito M, Nanjo M, Kataoka M, Moriya Y, Sugawara Y, Yoshida T, Ishida N.
    Cancer Res; 1988 Aug 01; 48(15):4163-7. PubMed ID: 3390809
    [Abstract] [Full Text] [Related]

  • 8. [Oral administration of streptococcal preparation "OK 432 (picibanil)"--the second report: experimental studies on its absorption and the responses of the gut associated lymphoid tissue].
    Nio Y, Ohgaki K, Inamoto T, Hori T, Nakayama N, Yamasaki N, Kan N, Hikasa Y, Tsuchitani T, Nagai T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Feb 20; 19(1):71-9. PubMed ID: 6527068
    [No Abstract] [Full Text] [Related]

  • 9. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M, Makita F, Takeyoshi I, Ishikawa H, Nakamura S, Owada S, Miyamoto Y, Izuo M, Kurashige S.
    Jpn J Surg; 1990 May 20; 20(3):316-26. PubMed ID: 2359208
    [Abstract] [Full Text] [Related]

  • 10. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y, Tobe T.
    Nihon Geka Gakkai Zasshi; 1989 Sep 20; 90(9):1436-8. PubMed ID: 2586435
    [Abstract] [Full Text] [Related]

  • 11. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
    Inoh A, Kodama Y, Yokoro K.
    Hiroshima J Med Sci; 1989 Dec 20; 38(4):213-9. PubMed ID: 2637250
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M, Takashige K, Furuyashiki M, Yoshidome K, Sano R, Kawamura Y, Ijichi S, Morioka H, Koide H, Oku N, Moriya Y, Kusumoto S, Suda Y.
    Int Immunopharmacol; 2008 Jan 20; 8(1):12-9. PubMed ID: 18068095
    [Abstract] [Full Text] [Related]

  • 13. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct 20; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract] [Full Text] [Related]

  • 14. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y, Hirata H, Sakamoto K, Sato M, Morikage T, Maruyama M, Sasaki K, Yano S.
    Gan To Kagaku Ryoho; 1987 Sep 20; 14(9):2710-5. PubMed ID: 3631971
    [Abstract] [Full Text] [Related]

  • 15. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H, Oshima H, Soma G, Mizuno D.
    J Biol Response Mod; 1988 Dec 20; 7(6):596-607. PubMed ID: 3216223
    [Abstract] [Full Text] [Related]

  • 16. Stable long-term induction of perforin-positive CD8+ T cells in gut by oral administration of streptococcal preparation OK-432.
    Mino N, Naomoto Y, Shirakawa Y, Matsuoka J, Nobuhisa T, Gunduz M, Noma K, Nagatsuka H, Kobayashi M, Yamatsuji T, Haisa M, Gochi A, Tanaka N.
    Int J Mol Med; 2004 Nov 20; 14(5):801-6. PubMed ID: 15492848
    [Abstract] [Full Text] [Related]

  • 17. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):609-17. PubMed ID: 2932509
    [No Abstract] [Full Text] [Related]

  • 18. Combination chemo-immunotherapy of murine solid tumor with OK-432, G-CSF, IL-2, and chemotherapeutics.
    Iida S, Matsuoka S, Kudo C, Moriya Y, Yoshida T, Saito M.
    Int J Immunopharmacol; 1995 Dec 20; 17(12):973-80. PubMed ID: 8964656
    [Abstract] [Full Text] [Related]

  • 19. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May 20; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 20. [The effect of OK-432 on modifying a spontaneous lung metastasis from murine fibrosarcomas].
    Ito H, Yamada S, Nishiguchi I, Shigematsu N, Nakayama T, Kuribayashi T, Hashimoto S.
    Gan No Rinsho; 1990 Aug 20; 36(9):993-7. PubMed ID: 2381054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.